MECHANISM OF ALLOXAN DIABETES INHIBITION BY VASOPRESSOR DRUGS

被引：0

|

作者：

MEADE, RC

KLITGAARD, HM

机构：

来源：

AMERICAN JOURNAL OF PHYSIOLOGY | 1960年 / 199卷 / 01期

关键词：

D O I：

暂无

中图分类号：

Q4 [生理学];

学科分类号：

071003 ;

摘要：

引用

收藏

页码：25 / 27

页数：3

相关论文

共 50 条

[21] ALLOXAN DIABETES
BAILEY, CC
VITAMINS AND HORMONES, 1949, 7 : 365 - 382
[22] ALLOXAN DIABETES
LUKENS, FDW
PHYSIOLOGICAL REVIEWS, 1948, 28 (03) : 304 - 330
[23] THE EFFECT OF ALLOXAN DIABETES ON EXPERIMENTAL CHOLESTEROL ATHEROSCLEROSIS IN THE RABBIT .1. THE INHIBITION OF EXPERIMENTAL CHOLESTEROL ATHEROSCLEROSIS IN ALLOXAN DIABETES .2. THE EFFECT OF ALLOXAN DIABETES ON THE RETROGRESSION OF EXPERIMENTAL CHOLESTEROL ATHEROSCLEROSIS
DUFF, GL
MCMILLAN, GC
JOURNAL OF EXPERIMENTAL MEDICINE, 1949, 89 (06): : 611 - 630
[24] MECHANISM OF INCREASED RENAL TUBULAR REABSORPTION OF DRUGS IN ALLOXAN DIABETIC RABBITS
NISHIHATA, T
YATA, N
KAMADA, A
CHEMICAL & PHARMACEUTICAL BULLETIN, 1978, 26 (11) : 3378 - 3383
[25] STUDIES ON MECHANISM OF ALLOXAN INHIBITION OF GLUCOSE-INDUCED INSULIN RELEASE
ISHIBASHI, F
ONARI, K
SATO, T
KAWATE, R
HIROSHIMA JOURNAL OF MEDICAL SCIENCES, 1978, 27 (03) : 211 - 219
[26] MECHANISM OF INHIBITION OF MYELOPEROXIDASE BY ANTIINFLAMMATORY DRUGS
KETTLE, AJ
WINTERBOURN, CC
BIOCHEMICAL PHARMACOLOGY, 1991, 41 (10) : 1485 - 1492
[27] MECHANISM OF PROTECTION FROM ALLOXAN DIABETES PROVIDED BY NORMAL-BUTANOL
SCHAUBERGER, CW
THIES, RL
FISCHER, LJ
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 1977, 201 (02): : 450 - 455
[28] INHIBITION OF VASOPRESSOR RESPONSES BY CADMIUM
THIND, GS
STEPHAN, KF
BLAKEMORE, WS
AMERICAN JOURNAL OF PHYSIOLOGY, 1970, 219 (03): : 577 - +
[29] THE MECHANISM OF THE PROTECTIVE ACTION OF CLAMPING THE RENAL PEDICLES OF DOGS WITH ALLOXAN DIABETES
ARTETA, JL
JOURNAL OF ENDOCRINOLOGY, 1952, 8 (03) : 245 - &
[30] HEMODYNAMIC SPECTRUM OF VASOPRESSOR AND VASODILATOR DRUGS
LEWIS, CM
WEIL, MH
JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1969, 208 (08) : 1391 - +

← 1 2 3 4 5 →